DK0546076T3 - Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock - Google Patents

Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock

Info

Publication number
DK0546076T3
DK0546076T3 DK91916518T DK91916518T DK0546076T3 DK 0546076 T3 DK0546076 T3 DK 0546076T3 DK 91916518 T DK91916518 T DK 91916518T DK 91916518 T DK91916518 T DK 91916518T DK 0546076 T3 DK0546076 T3 DK 0546076T3
Authority
DK
Denmark
Prior art keywords
drug
prepare
treatment
endotoxic shock
icam antibodies
Prior art date
Application number
DK91916518T
Other languages
English (en)
Inventor
Lindsay Gordon Letts
Steven M Weldon
Genus J Possanza
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0546076T3 publication Critical patent/DK0546076T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK91916518T 1990-08-31 1991-08-30 Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock DK0546076T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57913790A 1990-08-31 1990-08-31
PCT/US1991/006219 WO1992004034A1 (en) 1990-08-31 1991-08-30 Method for treating endotoxin shock using anti-adhesion antibodies

Publications (1)

Publication Number Publication Date
DK0546076T3 true DK0546076T3 (da) 1998-10-19

Family

ID=24315708

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91916518T DK0546076T3 (da) 1990-08-31 1991-08-30 Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock

Country Status (11)

Country Link
EP (1) EP0546076B1 (da)
JP (1) JPH06501931A (da)
AT (1) ATE166230T1 (da)
AU (1) AU645348B2 (da)
CA (1) CA2090464A1 (da)
DE (1) DE69129460T2 (da)
DK (1) DK0546076T3 (da)
ES (1) ES2115618T3 (da)
HU (1) HU216097B (da)
RU (1) RU2123861C1 (da)
WO (1) WO1992004034A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891841A (en) * 1991-06-11 1999-04-06 The Center For Blood Research, Inc. Methods of using intercellular adhesion molecule-3 (ICAM-3), antibodies thereto, and soluble fragments thereof
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
US5702917A (en) * 1992-01-27 1997-12-30 Icos Corporation Polynucleotides encoding human ICAM-4
US5700658A (en) * 1992-01-27 1997-12-23 Icos Corporation ICAM-4 materials and methods
US5773218A (en) * 1992-01-27 1998-06-30 Icos Corporation Method to identify compounds which modulate ICAM-related protein interactions
CA2107097A1 (en) * 1992-01-27 1993-07-28 Michael W. Gallatin Icam-related protein
US5852170A (en) * 1992-01-27 1998-12-22 Icos Corporation ICAM-4 materials and methods
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US5773293A (en) * 1992-01-27 1998-06-30 Icos Corporation Anti-ICAM-4 antibodies and hybridomas
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
US5753502A (en) * 1993-08-05 1998-05-19 Icos Corporation Neuron-specific ICAM-4 promoter
US5854070A (en) * 1992-07-16 1998-12-29 Icos Corporation Murine and humanizer 23F2G antibodies and cell lines expressing said antibodies
EP0604647A4 (en) 1992-07-16 1996-09-25 Icos Corp Alleviation of symptoms associated with inflammatory disease states.
MX9305070A (es) * 1992-08-21 1994-04-29 Genentech Inc Compocicion farmaceutica que contiene un antagonista de lfa-1 para el tratamiento de transtornos o desordenes mediados por el lfa-1
US5695760A (en) * 1995-04-24 1997-12-09 Boehringer Inglehiem Pharmaceuticals, Inc. Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation
JP3813450B2 (ja) * 2000-02-29 2006-08-23 古河電気工業株式会社 半導体レーザ素子

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2064327T3 (es) * 1987-11-02 1995-02-01 Baylor College Medicine Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma

Also Published As

Publication number Publication date
EP0546076A1 (en) 1993-06-16
ES2115618T3 (es) 1998-07-01
HU9300538D0 (en) 1993-05-28
DE69129460D1 (de) 1998-06-25
JPH06501931A (ja) 1994-03-03
EP0546076B1 (en) 1998-05-20
ATE166230T1 (de) 1998-06-15
DE69129460T2 (de) 1998-10-15
HU216097B (hu) 1999-04-28
HUT70566A (en) 1995-10-30
AU645348B2 (en) 1994-01-13
WO1992004034A1 (en) 1992-03-19
RU2123861C1 (ru) 1998-12-27
CA2090464A1 (en) 1992-03-01
AU8502791A (en) 1992-03-30
EP0546076A4 (en) 1993-08-04

Similar Documents

Publication Publication Date Title
DK0546076T3 (da) Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock
DK0966447T3 (da) Anvendelige små molekyler til behandling af betændelsessygdomme
EA200200503A1 (ru) Способ лечения ревматоидного артрита
ATE330631T1 (de) Antikörperfragmente zur lokalen behandlung von augenerkrankungen
RU93004982A (ru) Способ лечения эндотоксинового шока с применением антиадгезивных антител
DK442688D0 (da) Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser
DK0506785T3 (da) Forbedret behandling af autoimmune sygdomme ved aerosol-administration af autoantigener
DK1212422T3 (da) Humane CTLA-4-antistoffer og anvendelserne deraf
EA200100822A1 (ru) Baff, относящиеся к нему блокирующие агенты и их применение в стимуляции и ингибировании b-клеток и иммуноглобулинов в иммунных реакциях
BR9707819A (pt) Imunogenos peptidicos
DK0514452T3 (da) Anvendelse af insulin-sensibiliserende midler til behandling af hypertension
NO910209L (no) Fremgangsmaate for fremstilling av rekombinante humane anti-cd18-antistoffer.
DE69125485T2 (de) Verfahren und zwischenprodukte synthetischer antikörperderivate
DE69029858D1 (de) Behandlung von einer autoimmun-krankheit
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DE69615685D1 (de) Impstoff gegen krankheitserreger, zusammensetzung zur behandlung und vorbeugung von hiv infektionen
DK40691D0 (da) Fremgangsmaade til chargevis regenereringsbehandling af overvejende lerbundet, brugt stoebesand
DK0517787T3 (da) Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide
ATE134649T1 (de) Arzneimittel und verfahren zur behandlung von erworbenem immundefizienzsyndrom (aids) und aids- verwandtem komplex unter verwendung von karbohydratspezifischen antikörpern
DK40791D0 (da) Fremgangsmaade til regenereringsbehandling af overvejende lerbundet, brugt stoebesand
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
NL194693B (nl) Werkwijze voor het bereiden van medicinale preparaten voor het behandelen van diabetes.
ATE110786T1 (de) Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa.
ATE126704T1 (de) Bcrf1-antagonisten zur behandlung von epstein- barr-virus-infektionen.
DE69010897T2 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.